Future investigation is needed to further elucidate the relationship between obesity, glucose intolerance and IGF-IGFBP- system and prostatic growth, targeting to new treatment strategies focused on diet, exercise, and drugs inhibiting prostate cell proliferation. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.